Global 5-Azacytidine Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global 5-Azacytidine Market Research Report 2024
Azacitidine (5-azacytidine) is a chemical analogue of the cytosine nucleoside present in DNA and RNA. It induces antineoplastic activity by inhibiting DNA methyltransferase at low doses and inducing cytotoxicity by incorporating itself into RNA and DNA at high doses.
According to Mr Accuracy reports new survey, global 5-Azacytidine market is projected to reach US$ 133.5 million in 2029, increasing from US$ 78 million in 2022, with the CAGR of 7.4% during the period of 2024 to 2029.
Azacitidine is an anticancer drug used to treat myelodysplastic syndrome (MDS), acute myeloid leukemia, and other cancers. Azacitidine promotes cell differentiation by affecting DNA methylation patterns involved in gene expression. It also inhibits telomerase activity, thereby inhibiting proliferation, which leads to apoptosis. This has led to its use not only in the treatment of myelodysplastic syndromes, but also in the treatment of various types of cancer, including leukemia, lymphoma, breast cancer, and more. Growth factors for the azacitidine market include increasing prevalence of blood disorders globally and technological advancements in healthcare. However, high cost associated with treatment may hamper the growth of the market to some extent.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global 5-Azacytidine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Teva Pharmaceutical Industries
Tecoland
Intas Pharmaceuticals
Huzhou Zhanwang
Segment by Type
0.05g
0.1g
Others
Clinical
Non-clinical
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The 5-Azacytidine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global 5-Azacytidine market is projected to reach US$ 133.5 million in 2029, increasing from US$ 78 million in 2022, with the CAGR of 7.4% during the period of 2024 to 2029.
Azacitidine is an anticancer drug used to treat myelodysplastic syndrome (MDS), acute myeloid leukemia, and other cancers. Azacitidine promotes cell differentiation by affecting DNA methylation patterns involved in gene expression. It also inhibits telomerase activity, thereby inhibiting proliferation, which leads to apoptosis. This has led to its use not only in the treatment of myelodysplastic syndromes, but also in the treatment of various types of cancer, including leukemia, lymphoma, breast cancer, and more. Growth factors for the azacitidine market include increasing prevalence of blood disorders globally and technological advancements in healthcare. However, high cost associated with treatment may hamper the growth of the market to some extent.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global 5-Azacytidine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Teva Pharmaceutical Industries
Tecoland
Intas Pharmaceuticals
Huzhou Zhanwang
Segment by Type
0.05g
0.1g
Others
Segment by Application
Clinical
Non-clinical
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The 5-Azacytidine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source